Headquartered in Alameda, California, Penumbra, Inc. is a global healthcare company focused on interventional therapies. We design, develop, manufacture and market innovative devices. We have a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.

Today, we have sales operations in North America, Europe, Australia, Asia, and South America.

NYSE: PEN 85.00 +0.00 +0%
Volume: 138,100
Pricing delayed 20 minutes August 22, 2017 05:00 PM

SEC Filings

IR Contact


Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502